Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries. / Maret-Ouda, John; Wahlin, Karl; Artama, Miia; Brusselaers, Nele; Farkkila, Martti; Lynge, Elsebeth; Mattsson, Fredrik; Pukkala, Eero; Romundstad, Pal; Tryggvadottir, Laufey; von Euler-Chelpin, My; Lagergren, Jesper.

In: JAMA Oncology, Vol. 4, No. 11, 2018, p. 1576-1582.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Maret-Ouda, J, Wahlin, K, Artama, M, Brusselaers, N, Farkkila, M, Lynge, E, Mattsson, F, Pukkala, E, Romundstad, P, Tryggvadottir, L, von Euler-Chelpin, M & Lagergren, J 2018, 'Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries', JAMA Oncology, vol. 4, no. 11, pp. 1576-1582. https://doi.org/10.1001/jamaoncol.2018.3054

APA

Maret-Ouda, J., Wahlin, K., Artama, M., Brusselaers, N., Farkkila, M., Lynge, E., ... Lagergren, J. (2018). Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries. JAMA Oncology, 4(11), 1576-1582. https://doi.org/10.1001/jamaoncol.2018.3054

Vancouver

Maret-Ouda J, Wahlin K, Artama M, Brusselaers N, Farkkila M, Lynge E et al. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries. JAMA Oncology. 2018;4(11):1576-1582. https://doi.org/10.1001/jamaoncol.2018.3054

Author

Maret-Ouda, John ; Wahlin, Karl ; Artama, Miia ; Brusselaers, Nele ; Farkkila, Martti ; Lynge, Elsebeth ; Mattsson, Fredrik ; Pukkala, Eero ; Romundstad, Pal ; Tryggvadottir, Laufey ; von Euler-Chelpin, My ; Lagergren, Jesper. / Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries. In: JAMA Oncology. 2018 ; Vol. 4, No. 11. pp. 1576-1582.

Bibtex

@article{110928d8714f4d11acc34826adbbb391,
title = "Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries",
author = "John Maret-Ouda and Karl Wahlin and Miia Artama and Nele Brusselaers and Martti Farkkila and Elsebeth Lynge and Fredrik Mattsson and Eero Pukkala and Pal Romundstad and Laufey Tryggvadottir and {von Euler-Chelpin}, My and Jesper Lagergren",
year = "2018",
doi = "10.1001/jamaoncol.2018.3054",
language = "English",
volume = "4",
pages = "1576--1582",
journal = "JAMA Oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "11",

}

RIS

TY - JOUR

T1 - Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries

AU - Maret-Ouda, John

AU - Wahlin, Karl

AU - Artama, Miia

AU - Brusselaers, Nele

AU - Farkkila, Martti

AU - Lynge, Elsebeth

AU - Mattsson, Fredrik

AU - Pukkala, Eero

AU - Romundstad, Pal

AU - Tryggvadottir, Laufey

AU - von Euler-Chelpin, My

AU - Lagergren, Jesper

PY - 2018

Y1 - 2018

U2 - 10.1001/jamaoncol.2018.3054

DO - 10.1001/jamaoncol.2018.3054

M3 - Journal article

VL - 4

SP - 1576

EP - 1582

JO - JAMA Oncology

JF - JAMA Oncology

SN - 2374-2437

IS - 11

ER -

ID: 210011863